MicroRNAs control herpesviral dormancy

Tumor Virology Program, Greehey Children's Cancer Research Institute, Department of Pediatrics, Microbiology and Immunology, Medicine, and Molecular Medicine, and Cancer Therapy and Research Center, University of Texas Health Science Center at San Antonio, San Antonio, TX USA.
Cell cycle (Georgetown, Tex.) (Impact Factor: 4.57). 04/2010; 9(7):1225-6. DOI: 10.4161/cc.9.7.11387
Source: PubMed


Infections by herpesviruses are widespread in humans, and are the causes for several important diseases. Gammaherpesvirus Kaposi's sarcoma-associated herpesvirus (KSHV) is etiologically associated with Kaposi's sarcoma (KS), a highly inflammatory and angiogenic cancer commonly found in AIDS patients.1 KSHV is also associated with primary effusion lymphoma and a subset of multicentric Castleman’s disease, two rare lymphoproliferative malignancies.

Download full-text


Available from: Shou-Jiang Gao
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Hematopoietic stem cells (HSCs) give rise to all lineages of blood cells. Because HSCs must persist for a lifetime, the balance between their proliferation and quiescence is carefully regulated to ensure blood homeostasis while limiting cellular damage. Cell cycle regulation therefore plays a critical role in controlling HSC function during both fetal life and in the adult. The cell cycle activity of HSCs is carefully modulated by a complex interplay between cell-intrinsic mechanisms and cell-extrinsic factors produced by the microenvironment. This fine-tuned regulatory network may become altered with age, leading to aberrant HSC cell cycle regulation, degraded HSC function, and hematological malignancy.
    Full-text · Article · Nov 2011 · The Journal of Cell Biology
  • [Show abstract] [Hide abstract]
    ABSTRACT: Human retrovirus HTLV-1 replication and spread are controlled by different viral and cellular factors. Although several anti-HIV cellular microRNAs have been described, such regulation for HTLV-1 has not been reported. In this study, we found that miR-28-3p inhibits HTLV-1 virus expression and its replication by targeting a specific site within the genomic gag/pol viral mRNA. Since miR-28-3p is highly expressed in resting T cells, which are resistant to HTLV-1 infection, we investigate a potential protective role of miR-28-3p against de novo HTLV-1 infection. To this end, we develop a new sensitive and quantitative assay based on the detection of products of reverse transcription. We demonstrate that miR-28-3p does not prevent virus receptor interaction or virus entry but instead induces a post-entry block at the reverse transcription level. In addition, we found that HTLV-1 subtype 1A isolates, corresponding to the Japanese strain ATK-1, present a natural single nucleotide polymorphism within the miR-28-3p target site. As a result of this polymorphism, the ATK-1 virus sequence was not inhibited by miR-28. Interestingly, genetic studies on transmission of virus had shown that the ATK-1 strain, which carries a T-to-C transition mutation, was efficiently transmitted between spouses, suggesting that miR-28 may play an important role in HTLV-1 transmission. Copyright © 2015, The American Society for Biochemistry and Molecular Biology.
    No preview · Article · Jan 2015 · Journal of Biological Chemistry
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Human T-cell leukemia virus (HTLV)-1 is a human retrovirus and the etiological agent of adult T-cell leukemia/lymphoma (ATLL), a fatal malignancy of CD4/CD25+ T lymphocytes. In recent years, cellular as well as virus-encoded microRNA (miRNA) have been shown to deregulate signaling pathways to favor virus life cycle. HTLV-1 does not encode miRNA, but several studies have demonstrated that cellular miRNA expression is affected in infected cells. Distinct mechanisms such as transcriptional, epigenetic or interference with miRNA processing machinery have been involved. This article reviews the current knowledge of the role of cellular microRNAs in virus infection, replication, immune escape and pathogenesis of HTLV-1.
    Full-text · Article · Jul 2015 · Viruses